These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 187004)

  • 1. Basal and hormone-induced urinary cyclic AMP in children with renal disorders.
    Monn E; Osnes JB; Oye I
    Acta Paediatr Scand; 1976 Nov; 65(6):739-45. PubMed ID: 187004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
    McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
    Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):485-90. PubMed ID: 2986401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C; Galli M; Montagnani M; D'Amore I
    Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.
    Uttley WS; Atkinson B; Adams A; Shirling D
    J Inherit Metab Dis; 1978; 1(2):75-7. PubMed ID: 229343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial cases of congenital nephrogenic diabetes insipidus type II: Remarkable increment of urinary adenosine 3',5'-monophosphate in response to antidiuretic hormone.
    Ohzeki T; Igarashi T; Okamoto A
    J Pediatr; 1984 Apr; 104(4):593-5. PubMed ID: 6323666
    [No Abstract]   [Full Text] [Related]  

  • 7. Congenital nephrogenic diabetes insipidus in a baby girl.
    Schreiner RL; Skafish PR; Anand SK; Northway JD
    Arch Dis Child; 1978 Nov; 53(11):906-8. PubMed ID: 215090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium-induced nephrogenic diabetes insipidus: in vivo and in vitro studies.
    Singer I; Rotenberg D; Puschett JB
    J Clin Invest; 1972 May; 51(5):1081-91. PubMed ID: 4341501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Effect of vasopressin and chlorpropamide.
    Raij K; Perheentupa J; Härkönen M
    Scand J Clin Lab Invest; 1974 Oct; 34(2):177-84. PubMed ID: 4370673
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of exogenous 3':5'-adenosine monophosphate on urinary output in children with vasopressin-resistant diabetes insipidus.
    Proesmans W; Eggermont E; Vanderschueren-Lodeweyckx M; Tiddens H; Eeckels R
    Pediatr Res; 1975 May; 9(5):509-12. PubMed ID: 166349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP responses to parathyroid hormone and glucagon during lithium treatment.
    Waller DG; Albano JD; Millar JG; Polak A
    Clin Sci (Lond); 1984 May; 66(5):557-9. PubMed ID: 6323091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent nephrogenic diabetes insipidus, tubular proteinuria, aminoaciduria, and parathyroid hormone resistance following longterm lithium administration.
    Neithercut WD; Spooner RJ; Hendry A; Dagg JH
    Postgrad Med J; 1990 Jun; 66(776):479-82. PubMed ID: 2170960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiuretic and urinary cyclic AMP response of vasopressin in normal rats and in rats with lithium-polyuria.
    Christensen S; Geisler A
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):447-54. PubMed ID: 190861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.
    Dousa TP; Valtin H
    J Clin Invest; 1974 Sep; 54(3):753-62. PubMed ID: 4368480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary cyclic AMP and renal concentrating capacity in infants.
    Joppich R; Kollmann D; Ingrisch U; Weber P
    Eur J Pediatr; 1977 Jan; 124(2):113-9. PubMed ID: 188657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of the urinary concentrating defect in mice with nephrogenic diabetes insipidus.
    Valtin H; Coffey AK; O'Sullivan DJ; Homma S; Dousa TP
    Physiol Bohemoslov; 1990; 39(1):103-11. PubMed ID: 2165265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient renal cyclic adenosine 3'-5' monophosphate production in nephrogenic diabetes insipidus.
    Fichman MP; Brooker G
    J Clin Endocrinol Metab; 1972 Jul; 35(1):35-47. PubMed ID: 4338115
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to ADH in nephrogenic diabetes insipidus type 2.
    Yasuda T; Nakajima H
    J Pediatr; 1984 Nov; 105(5):850-1. PubMed ID: 6094779
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary cyclic-3', 5'-adenosine monophosphate in normal children and in those with disease conditions].
    Tsuchiya Y; Matsuo N; Cho H; Kumagaya M
    Horumon To Rinsho; 1977 Sep; 25(9):1003-10. PubMed ID: 200383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.